Song Kyungsub, Kim Yun Seok, Jang Woo Sung, Chung Suryeun, Cho Yang Hyun, Jeong Dong Seop, Kim Wook Sung, Sung Kiick
Department of Thoracic and Cardiovascular Surgery, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea.
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
J Thorac Dis. 2023 Aug 31;15(8):4357-4366. doi: 10.21037/jtd-23-331. Epub 2023 Jul 31.
There is not sufficient evidence of the superiority of hybrid procedures over total arch replacement (TAR) for the aortic arch aneurysm of an elderly patients. This retrospective study aimed to compare total arch replacement and hybrid procedures for treatment of aortic arch aneurysms in patients aged ≥75.
This study was a multicenter retrospective investigation of peri-operative outcomes of patients undergoing aortic arch aneurysm repair using either TAR or hybrid procedures between January 2012 and May 2021. Risk factors for mortality were evaluated using multivariate analyses.
This study included 90 patients, of which 28 underwent hybrid procedures (hybrid group: frozen elephant trunk =9, zone 0 =6, zone 1 =1, zone 2 =12), and 62 underwent TAR (TAR group), and the mean duration of follow-up was 27.0±28.8 months. In patient characteristics, the incidence of chronic obstructive lung disease and chronic kidney disease in the TAR group was significantly higher than in the hybrid group, and other operative risk factors were not significantly different in both groups. No significant differences in the incidence of post-operative complications and mortality on hospitalization. Survival rates of both groups were not significantly different (P=0.31). However, re-intervention rates after aortic arch aneurysm repair were significantly higher in the hybrid group compared to the TAR group (freedom from re-intervention rates at 1, 3, 5 years: 100%, 93%, 93% in the TAR group, and 90%, 80%, 80% in the hybrid group, P=0.04).
There was no definitive evidence of the superiority of hybrid procedures over TAR, although the risk of re-intervention was higher in the former group. The surgical strategy for aortic arch aneurysms should be selected based on the patient's demographic and anatomical characteristics.
对于老年患者的主动脉弓部动脉瘤,杂交手术相对于全弓置换术(TAR)的优越性尚无充分证据。这项回顾性研究旨在比较年龄≥75岁患者的主动脉弓部动脉瘤全弓置换术和杂交手术的治疗效果。
本研究是一项多中心回顾性调查,调查了2012年1月至2021年5月期间接受TAR或杂交手术治疗主动脉弓部动脉瘤患者的围手术期结果。采用多因素分析评估死亡风险因素。
本研究纳入90例患者,其中28例行杂交手术(杂交组:象鼻支架植入术=9例,0区=6例,1区=1例,2区=12例),62例行TAR(TAR组),平均随访时间为27.0±28.8个月。在患者特征方面,TAR组慢性阻塞性肺疾病和慢性肾脏病的发生率显著高于杂交组,两组其他手术风险因素无显著差异。术后并发症发生率和住院死亡率无显著差异。两组生存率无显著差异(P=0.31)。然而,杂交组主动脉弓部动脉瘤修复术后再次干预率显著高于TAR组(1、3、5年无再次干预率:TAR组为100%、93%、93%,杂交组为90%、80%、80%,P=0.04)。
虽然杂交组再次干预风险较高,但尚无确凿证据表明杂交手术优于TAR。主动脉弓部动脉瘤的手术策略应根据患者的人口统计学和解剖学特征来选择。